当前位置:首页 - 行情中心 - 海利生物(603718) - 财务分析

海利生物

(603718)

  

流通市值:44.39亿  总市值:45.00亿
流通股本:6.49亿   总股本:6.58亿

海利生物(603718)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.15亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益122567.01万元,未分配利润30840.89万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产162371.57万元,负债39804.56万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入174,428,026.55107,598,422.270,304,397.74240,722,981.59
营业总成本210,114,237.84132,630,744.7679,483,781.34247,650,829.86
营业利润-27,413,235.16-18,237,339.45-5,513,186.8455,170,626.93
利润总额7,277,269.6416,482,302.99-5,525,992.3456,022,479.83
净利润15,408,989.9810,376,109.43-4,361,103.2250,013,768.17
其他综合收益1,568,638.59-8,903,502.5-8,270,656.0913,001,673.01
综合收益总额16,977,628.571,472,606.93-12,631,759.3163,015,441.18
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,169,792,575.23523,376,933.68556,092,338.5562,551,299.58
非流动资产合计453,923,093.871,079,772,801.071,089,073,221.311,095,198,483.76
资产总计1,623,715,669.11,603,149,734.751,645,165,559.811,657,749,783.34
流动负债合计371,043,389.44371,416,208.7398,839,157.29417,037,055.21
非流动负债合计27,002,181.0722,579,465.9765,621,331.8865,920,516.17
负债合计398,045,570.51393,995,674.67464,460,489.17482,957,571.38
归属于母公司股东权益合计1,272,862,793.231,256,089,662.681,223,533,561.831,216,978,966.74
股东权益合计1,225,670,098.591,209,154,060.081,180,705,070.641,174,792,211.96
负债和股东权益合计1,623,715,669.11,603,149,734.751,645,165,559.811,657,749,783.34
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计166,910,098.43116,018,841.3456,716,313.03283,034,733.77
经营活动现金流出小计145,227,574.52104,351,966.0157,946,047.77291,402,014.15
经营活动产生的现金流量净额21,682,523.9111,666,875.33-1,229,734.74-8,367,280.38
投资活动现金流入小计559,112,248.43246,185,168.83151,043,125.22800,342,761.2
投资活动现金流出小计594,939,464323,387,496219,854,008971,431,779.51
投资活动产生的现金流量净额-35,827,215.57-77,202,327.17-68,810,882.78-171,089,018.31
筹资活动现金流入小计58,413,42935,000,00020,000,000266,442,000
筹资活动现金流出小计103,833,995.7674,386,308.3630,434,991.67106,449,657.42
筹资活动产生的现金流量净额-45,420,566.76-39,386,308.36-10,434,991.67159,992,342.58
汇率变动对现金及现金等价物的影响-5,721.113,020.5684.154,619.06
现金及现金等价物净增加额-59,570,979.53-104,918,739.7-80,474,925.04-19,459,337.05
期末现金及现金等价物余额77,522,211.0832,174,450.9156,618,265.57137,093,190.61
TOP↑